From the Editor's Desk
December 2014 Global Forum Now Online: It's a brave new world for pharmacovigilance, and safety and risk management; and a brand new day for eRegulatory & intelligence management, too. In this issue, read detailed interviews with expert leadership from two of DIA's most enduring and yet newest educational programs, Pharmacovigilance & Risk Management Strategies 2015, and debut eRegulatory & Intelligence Annual Conference. Plus special reports from our 5th Cardiac Safety Workshop in Japan, Patient Engagement Workshop, and Pediatric Research 2014 Conference, and a personal invitation to the 4th African Regulatory Conference: Moving towards Regulatory Harmonization to Enhance Access to Medicines in Africa.
Read the December issue.
Biosimilars Challenge Pharma
Driving the burgeoning biosimilars industry is a lucrative biologics market, with multiple drug patents set to expire soon. Read about this important issue and happenings at the DIA Biosimilars 2014 conference held in Washington, DC in September 2014.
Ebola Information Resources and Reference Material
CE providers have been asked to share educational resources and reference material from the American Hospital Association (AHA) and the Centers for Disease Control and Prevention (CDC). The information is current as of dates indicated below. Please continue to consult the CDC other public health sources to ensure accuracy and identify additional information that may be available.
Read Information from the AHA regarding Ebola Facts: Surgical Protocol – Possible or Confirmed Ebola Cases (10/16/14)
Read AHA Ebola Facts: Hospital Preparedness Checklist (10/15/14)
Read CDC Information for Healthcare Workers and Settings
Read AHA Ebola Facts, Educational PowerPoint Slides (10/14/14)
The AHA has provided an Ebola education package for CME providers and believes it would be beneficial to healthcare providers and institutions. (10/14/14)
Read FAQ on Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals
Editor In Chief Commentary: Therapeutic Innovation & Regulatory Science - November 2014 Steven P Spielberg MD, PhD discusses recent changes and improvements to the journal and to DIA publications.
Read full commentary.
Read more TIRS articles.
NEW! Read our blog.
Can a Natural Disaster Stall Scientific Research?
An interesting Letter to the Editor appeared in the November issue of DIA’s official journal, Therapeutic Innovation & Regulatory Science, the impact of the Great East Japan earthquake and tsunami in 2011 on research activities is discussed.
Read the full article.
DIA Launches New TIRS Blog
DIA’s journal, Therapeutic Innovation & Regulatory Science, has launched a new blog, titled “Collaborate to Innovate.” The blog aims to further public conversation about global therapeutic advances and regulatory policies by offering expert insight on current trends and fresh perspectives on timely industry news. Read the blog. Don’t forget to follow the blog to stay current on new entries.
The blog is just another facet of TIRS’ multimedia approach to industry news. We also offer monthly podcasts, featuring commentary by industry experts. They are available on the blog. Listen to Podcasts.
Both the blog and our podcasts are complimentary to all site visitors, so please share them with your professional network.
Global Chief Executive Barbara Lopez Kunz and Global Director of Engagement Elizabeth Lincoln were recently interviewed by International Innovation. Courtesy of International Innovation, a leading scientific dissemination service.
New! DIA Europe and Director Jytte Lyngvig were spotlighted in SCRIP100.com.
Read their profile "A Forum for Future Leaders."
What Lies Ahead for 2014?
DIA's second annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.
New! Content Currents
DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.
Read current issue.
Today's Top Story
In his article, EURO EXCHANGE, author Graham Hughes discusses this year’s 25th annual DIA Euromeeting in Amsterdam and reflects on his 15 years of attending DIA events.
Recent Press Releases
DIA 2015 51st Annual Meeting
Registration and Housing Now Open!
The DIA 2015 51st Annual Meeting
brings together a global community of life sciences professionals at all levels and across all disciplines all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. The DIA Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.
| Book Your Hotel
Highlights from DIA 2014 50th Annual Meeting:
Keynote Address from PatientsLikeMe’s Jaime Heywood
“There’s going to be a network of people coming into your future. They want to be your partner.
They want to be your friend. Your question is: How will you let them in?” - Jamie Heywood
View Daily Highlights
Monday, June 16 | Tuesday, June 17 | Wednesday, June 18 | Thursday, June 19
View More Highlights
Meetings & Training
DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations. Professional development options include:
Conferences & Meetings | In-Person Training | In-company Training |Online Learning | Certificate Programs
Upcoming educational opportunities in your region:
2014 DIA Japan Calendar of Events
New! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry
Just added! The Impact of Drug Shortages on the Pharmaceutical Industry
More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:
DIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:
- Share documents
- Engage in online discussions
- Post community event information
- Make announcements and post news
- Join Communities (formerly SIACs)
Exhibiting & Advertising
Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.
Contract Service Organization (CSO) Directory
Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.
View partner listings.
Join DIA and an anticipated 450+ companies with a booth at the DIA 2014 50th Annual Meeting!
Upcoming exhibiting opportunities in your region:
Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.
Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.
New Era for Communities
DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.
As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.
Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.
DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:
- Student Volunteer Program
- Young Professionals Fellowship Program
- Student Fellowship Program
- Complimentary EuroMeeting registration
- Student Poster Session (North America, Europe, China Annual Meetings)
- Discount registration (North America and Europe Annual Meetings)
- Group Discounts for DIA Student Chapter members
- Student Membership
- Student Engagement at DIA Annual Meeting
- Student Chapters
DIA 2014 50th Annual Meeting Student Session Reports
Monday, June 16
View Session 107. Pioneering Regenerative Medicine: Trends in Regulations for New Therapy
View Session 129. Regulatory Submissions: Better, Faster, and Cheaper
Tuesday, June 17
View Session 211. Clinical Outcomes Assessment & Patient Engagement Symposium
View Session 215. The Regulatory Intelligence Function: Evolution over the Past Decade in an Expanded Global Marketplace
View Session 221. Benefit-Risk Throughout the Life Cycle: How Should Benefit-Risk Be Evaluated and Communicated from Development through Marketing as New Information Emerges?
View Session 246. EMA-FDA Collaboration in Pharmacovigilance: Common Objectives & Common Challenges
View Session 262. First-in-Human Studies: How Much Complexity Is Too Much?
Wednesday, June 18
View Session 319. Signal Detection: Challenges & Strategic Aspects
EMA Press Release: Pharmacovigilance Risk Assessment Committee: One year of Public Health Promotion and Protection
Medical Students Remain Unfazed by Professors Industry Relationships
Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.